 Based on the multi mechanism antitumor strategy and the regulatory effect of nitric oxide on histone deacetylases a series of

@highlight Several class I selective HDAC inhibitors with NO releasing activity were developed.
@highlight The NO releasing activity of
@highlight contributed to its intracellular HDAC inhibition.
@highlight The dual biological activities endowed
@highlight with considerable antitumor potency.
